Use of botulinum toxin A in the treatment of intermittent exotropia

In this prospective cohort study, the authors aimed to evaluate the efficiency of botulinum toxin A (BTA) injection in the treatment of intermittent exotropia (IXT) and examine factors affecting treatment outcomes. Seventy-four patients diagnosed with any type of IXT were...

BT outcomes for accommodative esotropia

The purpose of this study was to study the effect of Botulinum Toxin (BT) in refractive and non-refractive accommodative esotropia unresponsive to glasses and poor compliance with glasses. This was a retrospective study of 114 patients who had BT for...

BT outcome for CP and ET

The authors evaluate the clinical outcome of botulinum toxin (BT) injection in the correction of esotropia in 44 patients with cerebral palsy (CP). BT was injected under general anaesthesia without EMG guidance. Of the children, 47.7% were male and mean...

BT for intermittent exotropia

This study aimed to evaluate the effect of botulinum toxin (BT) on the amount of deviation and fusional control state of intermittent exotropia. Twenty-one patients (five male and 16 female) aged five to 18 years with progression of exotropia were...